相关实验视频

Updated: Jul 9, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

粘膜活性药物和在肺部疾病治疗中的多种应用

Alexis Hocquigny¹, Hélène Hugerot², Rosy Ghanem³

¹Univ Brest, INSERM, EFS, UMR 1078, GGB, F-29200 Brest, France.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

|December 4, 2023

概括

本综述探讨了用于治疗COPD和囊性纤维化等肺部疾病中的粘液过分的粘液活性药物. 它详细介绍了药物机制和临床研究,以改善气道阻塞和肺功能.

科学领域:

肺部医学肺部医学
生物材料科学生物材料科学
药理学药理学是指药理学的学科.

背景情况:

粘液作为器官 (包括肺部) 中的重要防御障碍,防止病原体和维持平衡.
气道粘液的过度分泌是呼吸系统疾病的标志,例如慢性阻塞性肺病 (COPD) 和囊性纤维化 (CF).
过多的粘液阻塞呼吸道,降低肺功能和吸入药物的疗效.

研究的目的:

审查粘膜活性药物的分类和作用机制.
专注于粘膜活性药物的临床应用,用于治疗COPD和CF.
评估治疗策略,以减轻由粘液引起的呼吸道阻塞.

主要方法:

关于粘膜活性药物的科学文章和临床研究的文献综述.
粘液活性剂根据其治疗点 (排泄剂,粘液溶解剂,粘液动力学,粘液调节剂) 的分类.
对COPD和CF患者的粘液活性疗法的临床试验数据的分析.

主要成果:

粘液活性药物提供了多种机制来解决呼吸系统疾病中的粘液功能障碍.
临床研究表明,不同粘液活性剂在改善COPD和CF的粘液清除和肺功能方面具有不同的疗效.
优化粘液活性药物选择和应用对于有效的呼吸道管理至关重要.

结论:

粘液活性药物对于管理与粘液相关的呼吸道疾病至关重要.
需要进一步的研究和临床试验来完善使用粘膜活性剂治疗COPD和CF的治疗策略.
准粘液特性为在阻塞性肺病中恢复肺功能提供了一个有希望的途径.

关键词:

慢性阻塞性肺病是一种慢性阻塞性肺病.囊性纤维化囊性纤维化粘膜阻塞性疾病粘膜阻塞性疾病粘液活性药物粘液活性药物粘液粘液是一种粘液.肺部疾病肺部疾病

更多相关视频

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

In vivo Evaluation of Mucociliary Clearance in Mice

In vivo Evaluation of Mucociliary Clearance in Mice

Published on: December 18, 2020

相关概念视频

Drugs Used in Upper Respiratory Disorders: Overview

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

Antiasthma Drugs: Muscarinic Receptor Antagonists

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...